후두경 시장 : 세계 시장 예측(2026-2032년)

The Laryngoscope Market is projected to grow by USD 1,291.04 million at a CAGR of 6.85% by 2032.

The laryngoscope remains a critical airway management and diagnostic instrument across anesthesia, emergency medicine, otolaryngology, intensive care, and prehospital care. Demand is shaped by the global priority to improve first-pass intubation success, reduce airway-related complications, support minimally invasive visualization, and standardize safer procedures in high-acuity environments. Conventional direct laryngoscopes continue to serve as essential tools, while video laryngoscopes, flexible visualization systems, disposable blades, and integrated imaging solutions are increasingly embedded into clinical protocols for difficult airway management. The landscape is also influenced by rising surgical volumes, expanding critical care capacity, aging populations with higher procedural needs, infection prevention mandates, and continuous training requirements for clinicians managing complex airways.

Transformative Shifts in the Laryngoscope Landscape

The laryngoscope landscape is undergoing a meaningful transition from purely mechanical visualization toward digitally enabled, ergonomically refined, and infection-conscious airway solutions. Hospitals and ambulatory surgical centers are increasingly prioritizing video-assisted laryngoscopy for improved glottic visualization, particularly in anticipated and unanticipated difficult airway cases. Emergency departments and prehospital teams are adopting devices that support rapid deployment, rugged handling, and consistent visualization under time-sensitive conditions. At the same time, sterile single-use components are gaining relevance as facilities seek to reduce cross-contamination risks and simplify reprocessing workflows. Training is also shifting, with simulation-based education, standardized airway algorithms, and video playback supporting competency development. These changes are elevating expectations for device reliability, battery performance, display quality, blade design, interoperability, and ease of use across diverse clinical settings.

Cumulative Impact of Artificial Intelligence on Laryngoscopy

Artificial intelligence is beginning to influence the laryngoscope ecosystem by enhancing image interpretation, procedural guidance, workflow documentation, and training feedback. AI-enabled airway visualization can support real-time landmark recognition, tube placement assistance, and quality assessment of intubation attempts, particularly when paired with video laryngoscopy platforms. In education, machine learning tools can analyze recorded procedures to identify technique patterns, blade positioning, timing, and potential areas for improvement. In clinical operations, AI can help structure airway documentation, support device utilization analytics, and inform maintenance or readiness checks. While adoption depends on clinical validation, cybersecurity safeguards, regulatory clearance, and integration with hospital information systems, the cumulative impact of AI is expected to center on consistency, decision support, and measurable improvements in airway management quality rather than replacing clinician judgment.

Key Regional Insights for Laryngoscope Adoption

Asia-Pacific is characterized by expanding hospital infrastructure, growing surgical and emergency care capacity, and increasing adoption of video laryngoscopy in tertiary care centers, with China, India, Japan, Australia, and South Korea driving differentiated demand based on healthcare modernization, clinical training, and procurement standards. North America demonstrates mature uptake of advanced airway devices, supported by established anesthesia practices, emergency care protocols, simulation training, and strong emphasis on patient safety and documentation. Latin America is progressing through gradual modernization of operating rooms and emergency departments, with Brazil and Mexico playing important roles in widening access to advanced airway visualization while balancing cost and procurement constraints. Europe shows consistent demand for reusable and single-use laryngoscope solutions supported by stringent infection control expectations, medical device regulation, and standardized anesthesia guidelines across major healthcare systems. The Middle East is investing in advanced hospital networks, trauma care, and specialty surgical services, strengthening the need for reliable airway management devices in both public and private healthcare settings. Africa presents a mixed landscape in which urban referral hospitals increasingly seek durable and easy-to-maintain laryngoscopy tools, while broader adoption is shaped by workforce training, procurement budgets, equipment availability, and infrastructure readiness.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN countries are seeing rising interest in modern airway management as healthcare systems expand surgical access, emergency medicine capabilities, and clinician training programs, with procurement often emphasizing affordability, durability, and ease of maintenance. GCC countries are advancing adoption through investments in high-acuity hospitals, medical tourism infrastructure, emergency response systems, and specialized surgical services, creating favorable conditions for video laryngoscopy and standardized airway protocols. The European Union emphasizes compliance, safety, device traceability, infection prevention, and evidence-based procurement, which supports structured adoption of both reusable and disposable laryngoscope technologies. BRICS countries collectively represent diverse but important demand drivers, including large patient populations, expanding surgical procedures, public hospital modernization, and growing domestic healthcare capabilities. G7 countries generally demonstrate advanced clinical adoption, stronger integration of video-based airway tools into anesthesia and emergency medicine, and greater focus on training, quality assurance, and digital documentation. NATO member healthcare systems, particularly those with strong military and emergency preparedness priorities, place importance on rugged, portable, and rapidly deployable laryngoscope solutions suitable for trauma, field care, and critical response environments.

Key Country Insights for Laryngoscope Demand

The United States leads in advanced airway management adoption through broad use of video laryngoscopy in operating rooms, emergency departments, intensive care units, and training programs, while Canada emphasizes standardized care pathways, public procurement discipline, and patient safety outcomes. Mexico and Brazil are strengthening access to modern laryngoscopy through hospital upgrades and expanded surgical capacity, though purchasing decisions often weigh cost-efficiency and service support. The United Kingdom, Germany, France, Italy, and Spain demonstrate strong alignment with European clinical standards, infection prevention requirements, and structured anesthesia practices, supporting steady use of both direct and video laryngoscope systems. Russia maintains demand across large public hospital networks and emergency care settings, with procurement influenced by regional healthcare priorities and equipment availability. China is advancing rapidly through hospital modernization, domestic medical technology development, and broad expansion of surgical and critical care services, while India's growth is linked to increasing procedure volumes, private hospital expansion, and heightened focus on emergency airway readiness. Japan and South Korea show strong preference for technologically advanced, reliable, and clinically validated devices supported by sophisticated hospital infrastructure and training cultures. Australia combines advanced clinical practice with strong prehospital and remote-care considerations, making portability, reliability, and standardized airway training especially relevant.

Actionable Recommendations for Laryngoscope Industry Leaders

Industry leaders should prioritize clinically validated product design that improves visualization, supports first-pass success, and performs reliably across routine and difficult airway scenarios. Product portfolios should balance reusable and single-use options to address infection control, sustainability, and cost considerations across hospitals, ambulatory centers, emergency departments, and prehospital providers. Manufacturers and distributors should strengthen clinician education through simulation, procedure review tools, and standardized training partnerships. Regulatory readiness, cybersecurity for connected devices, evidence generation, and post-market surveillance should be built into commercialization strategies from the outset. Leaders should also invest in ergonomic blade designs, durable displays, long battery life, intuitive interfaces, and compatibility with existing airway workflows. In emerging healthcare systems, value-based positioning should emphasize durability, serviceability, training support, and total cost of ownership rather than only device acquisition cost.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified clinical, regulatory, and healthcare infrastructure sources. Inputs include peer-reviewed medical literature on airway management, anesthesia and emergency medicine guidelines, public health and hospital procurement references, medical device regulatory frameworks, infection prevention guidance, and country-level healthcare system indicators from authoritative public institutions. Qualitative synthesis is applied to evaluate adoption drivers, technology shifts, regional dynamics, clinical use cases, and operational priorities without presenting market sizing, share, or forecast figures. Findings are cross-checked for consistency across multiple credible sources, with emphasis on evidence-backed trends affecting laryngoscope design, procurement, clinical use, training, and digital transformation.

Conclusion

The laryngoscope sector is evolving from a traditional airway visualization category into a clinically sophisticated, digitally supported, and safety-driven field. The strongest momentum is linked to video laryngoscopy, difficult airway preparedness, infection control, simulation-based training, and the early integration of artificial intelligence into procedural support and education. Regional and country-level adoption patterns vary according to healthcare infrastructure, regulation, procurement models, and clinician training maturity, but the common direction is toward safer, more consistent, and more accountable airway management. Organizations that combine clinical evidence, usability, training support, regulatory discipline, and adaptable product strategies will be best positioned to meet the changing needs of modern airway care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Laryngoscope Market, by Product Type

• 7.1. Introduction
• 7.2. Flexible
• 7.3. Rigid

8. Laryngoscope Market, by Technology

• 8.1. Introduction
• 8.2. Fiber Optic
• 8.3. Video

9. Laryngoscope Market, by Usage

• 9.1. Introduction
• 9.2. Disposable
• 9.3. Reusable

10. Laryngoscope Market, by Patient Age

• 10.1. Introduction
• 10.2. Adult
• 10.3. Pediatric

11. Laryngoscope Market, by End User

• 11.1. Introduction
• 11.2. Ambulatory Surgical Centers
• 11.3. Clinics
• 11.4. Hospitals

12. Laryngoscope Market, by Application

• 12.1. Introduction
• 12.2. Diagnostic
• 12.3. Therapeutic
  • 12.3.1. Biopsy
  • 12.3.2. Foreign Body Removal
  • 12.3.3. Intubation

13. Laryngoscope Market, by Region

• 13.1. Asia-Pacific
• 13.2. Europe
• 13.3. North America
• 13.4. Latin America
• 13.5. Africa
• 13.6. Middle East

14. Laryngoscope Market, by Group

• 14.1. NATO
• 14.2. G7
• 14.3. BRICS
• 14.4. European Union
• 14.5. ASEAN
• 14.6. GCC

15. Laryngoscope Market, by Country

• 15.1. China
• 15.2. United States
• 15.3. Japan
• 15.4. India
• 15.5. Germany
• 15.6. United Kingdom
• 15.7. Australia
• 15.8. France
• 15.9. South Korea
• 15.10. Italy
• 15.11. Canada
• 15.12. Russia
• 15.13. Brazil
• 15.14. Mexico
• 15.15. Spain

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. FPNV Positioning Matrix, 2025
• 16.3. Market Concentration Analysis, 2025
  • 16.3.1. Concentration Ratio (CR)
  • 16.3.2. Herfindahl Hirschman Index (HHI)
• 16.4. Recent Developments & Impact Analysis, 2025
• 16.5. Product Portfolio Analysis, 2025
• 16.6. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Ambu A/S
• 17.2. Clarus Medical LLC
• 17.3. Flexicare Medical Limited
• 17.4. HEINE Optotechnik GmbH & Co. KG
• 17.5. Hill-Rom Holdings, Inc.
• 17.6. HOYA Corporation
• 17.7. Intersurgical Ltd.
• 17.8. KARL STORZ SE & Co. KG
• 17.9. Medtronic plc
• 17.10. Nihon Kohden Corporation
• 17.11. Olympus Corporation
• 17.12. Richard Wolf GmbH
• 17.13. Schoelly Fiberoptic GmbH
• 17.14. Shenda Endoscope Co., Ltd.
• 17.15. Smiths Medical, Inc.
• 17.16. Stryker Corporation
• 17.17. Teleflex Incorporated
• 17.18. Timesco Healthcare Ltd.
• 17.19. Venner Medical International Limited
• 17.20. Verathon Inc.
• 17.21. XION GmbH